Dr Reddy's shares slump 7% after USFDA's 'severe' observation of Hyderabad plant
In the past one month, six months and one year, the counter has given 0.49%, 16.77% and 23.70% in returns, respectively.
dr reddys shares
December 2023
July 2023
July 2022
Dr. Reddy's shares hit 52-week high as USFDA completes inspection of API plant
The pharma major received “zero observations” post the USFDA pre-approval inspection (PAI) and a routine GMP inspection at the Andhra Pradesh facility
Why are Dr. Reddy’s shares trading higher today
Dr. Reddy’s Laboratories has received the U.S. FDA approval to launch Fesoterodine Fumarate extended-release tablets in the American market
